Principles of economic evaluation in surgery

World Journal of Surgery

Volumn 23, Issue 12, 1999, Pages 1242-1248

  Krahn, Murray ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; COST BENEFIT ANALYSIS; HEALTH PROGRAM; HUMAN; MEDICAL DECISION MAKING; QUALITY OF LIFE; REVIEW; SURGEON; TREATMENT OUTCOME;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS; SURGICAL PROCEDURES, OPERATIVE;

EID: 0032709238     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900656     Document Type: Review

References (93)

1. Drummond, M., O'Brien, B., Stoddart, G., Torrance, G.: Methods for the Economic Evaluation of Health Care Programmes. Oxford, Oxford University Press, 1997
2. Elixhauser, A.: Health care cost-benefit and cost-effectiveness analyses from 1979 to 1990: a bibliography. Med. Care 31:JS139, 1993
3. Russell, L.B., Siegel, J.E., Daniels, N., Gold, M.R., Luce, B.R., Mandelblatt, J.S.: Cost-effectiveness analysis as a guide to resource allocation in health: roles and limitations. In Cost-Effectiveness in Health and Medicine, M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein, editors. New York, Oxford University Press, 1996
4. Luce, B.R., Brown, R.: The use of technology assessment by hospitals, health maintenance organizations, and third party payers in the United States. Int. J. Technol. Assess. Health Care 77:79, 1995
5. Henry, D.: Economic analysis as an aid to subsidisation decisions: the development of Australia's guidelines for pharmaceuticals. Pharmaco-economics 1:54, 1992
6. Detsky, A.S.: Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada. Pharmacoeconomics 3:354, 1993
7. Gold, M.R., Siegel, J.E., Russell, L.B., Weinstein, M.C.: Cost-effectiveness in Health and Medicine. New York, Oxford University Press, 1996
8. Task Force on Principles for Economic Analysis of Health Care Technology: Economic analysis of health care technology. Ann. Intern. Med. 122:61, 1995
9. Canadian Coordinating Office for Health Technology Assessment: A Guidance Document for the Costing Process (1st ed.). Ottawa, CCOHTA, 1996
10. Canadian Coordinating Office for Health Technology Assessment: Guidelines for Economic Evaluation of Pharmaceuticals (2nd ed.). Ottawa, CCOHTA, 1998
11. Eddy, D.M., Nugent, F.W., Eddy, J.F., Coller, J., Gilbertsen, V., Gottlieb, L.S., Rice, R., Sherlock, P., Winawer, S.: Screening for colorectal cancer in a high-risk population. Gastroenterology 92:682, 1987
12. Detsky, A.S., Naglie, I.G.: A clinician's guide to cost-effectiveness analysis. Ann. Intern. Med. 113:147, 1990
13. Bonsel, G.J., Rutten, F.F.H., Uyl-de Groot, C.A.: Economic evaluation alongside cancer trials: methodological and practical aspects. Eur. J. Cancer 29a:s10, 1993
14. Drummond, M.F., Davies, L.: Economic analysis alongside clinical trials: revisiting the methodological issues. Int. J. Technol. Assess. Health Care 7:561, 1991
15. Anderson, G.: A cost-effectiveness evaluation of 3 antimicrobial regimens for the prevention of infective complications after abdominal surgery. Arch. Surg. 131:744, 1996
16. Bonsel, G.J., Klompmaker, I.J., van't Veer, F., Habbema, J.D.F., Slooff, M.J.H.: Use of prognostic models for assessment of value of liver transplantation. Lancet 335:493, 1990
17. Van Hout, B.A., Bonsel, G.J., Habbema, J.D.F., van der Mass, P.J., de Charro, F.T.: Heart transplantation in The Netherlands. J. Health Econ. 12:73, 1993
18. Eddy, D.M.: The value of mammography screening in women under age 50 years. J.A.M.A. 259:1512, 1988
19. Krahn, M.D., Mahoney, J.E., Eckman, M.H., Trachtenberg, J., Pauker, S.G., Detsky, A.S.: Screening for prostate cancer: a decision analytic view. J.A.M.A. 272:781, 1994
20. Mushlin, A.I., Fintor, L.: Is screening for breast cancer cost-effective. Cancer 69:1957, 1992
21. King, J.T., Glick, H.A., Mason, T.J., Flamm, E.S.: Elective surgery for symptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis. J. Neurosurg. 83:403, 1995
22. Torrance, G.W., Feeny, D.: Utilities and quality-adjusted life years. Int. J. Technol. Assess. Health Care 5:559, 1989
23. Shepard, D.S., Weinstein, M.C.: Utility functions for life years and health status. Operations Res. 28:206, 1980
24. Mehrez, A., Gafni, A.: Quality adjusted life years, utility theory, and healthy year equivalents. Med. Decis. Making 9:142, 1989
25. Torrance, G.W.: Utility approach to measuring health-related quality of life. J. Chronic Dis. 40:593, 1987
26. Weinstein, M., Fineberg, H.: Clinical Decision Analysis. Philadelphia, W.B. Saunders, 1980
27. Phelps, C., Mushlin, A.I.: On the (near) equivalence of cost-effectiveness and cost-benefit analyses. Int. J. Technol. Assess. Health Care 7:12, 1991
28. Finkler, S.A.: The distinction between cost and charges. Ann. Intern. Med. 96:102, 1982
29. Eisenberg, J.M.: Clinical economics: a guide to the economic analysis of clinical practices. J.A.M.A. 262:2879, 1989
30. Pink, G.H., Bolley, H.B.: Physicians in health care management. 3. Case mix groups and resource intensity weights: an overview for physicians. Can. Med. Assoc. J. 150:889, 1994
31. Pink, G.H., Bolley, H.B.: Physicians in health care management. 4. Case mix groups and resource intensity weights: physicians and hospital funding. Can. Med. Assoc. J. 150:1255, 1994
32. Luce, B.R., Manning, W.G., Siegel, J.E., Lipscomb, J.: Estimating costs in cost-effectiveness analysis. In Cost-Effectiveness in Health and Medicine (1st ed.), M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein, editors. New York, Oxford University Press, 1996, pp. 176-213
33. Carter, R., Glasziou, P., van Ootmarssen, G., de Koning, H., Stevenson, C., Salkeld, G., Boer, R.: Cost-effectiveness of mammographie screening in Australia. Aust. J. Public Health 17:42, 1993
34. Cooper, B.S., Rice, D.P.: The economic costs of illness revisited. Soc. Sec. Bull. 39:21, 1976
35. Rice, D.P., Hodgson, T.A., Kopstein, A.N.: The economic costs of illness: a replication and update. Health Care Financ. Rev. 7:61, 1985
36. O'Brien, B., Viramontes, J.L.: Willingness to pay: a valid and reliable measure of health state preference. Med. Decis. Making 14:289, 1994
37. Robinson, J.C.: Philosophical origins of the economic valuation of life. Milbank Q. 64:133, 1986
38. Weinstein, M.C.: Principles of cost-effective resource allocation in health care organizations. Int. J. Technol. Assess. Health Care 6:93, 1990
39. Weinstein, M.C., Stason, W.B.: Foundations of cost-effectiveness analysis for health and medical practices. N. Engl. J. Med. 296:716, 1977
40. Krahn, M., Gafni, A.: Discounting in the evaluation of health care interventions. Med. Care 37:403, 1993
41. Olson, M., Bailey, M.J.: Positive time preference. J. Polit. Econ. 81:1, 1981
42. Fisher, I.: The Theory of Interest. London, Macmillan, 1935
43. Baumol, W.J.: On the social rate of discount. Am. Econ. Rev. 58:788, 1968
44. Feldstein, M.S.: The social time preference discount rate in cost benefit analysis. Econ. J. 74:360, 1964
45. Goodin, R.E.: Discounting discounting. J. Public Policy 2:53, 1982
46. Pigou, A.C.: The Economics of Welfare. London, Macmillan, 1920
47. Keeler, E.B., Cretin, S.: Discounting of life saving and other nonmonetary benefits. Manag. Sci. 29:300, 1983
48. Lipscomb, J., Weinstein, M.C., Torrance, G.W.: Time preference. In Cost Effectiveness in Health and Medicine, M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein, editors. New York, Oxford University Press, 1996
49. Briggs, A., Sculpher, M., Buxton, M.: Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ. 3:95, 1994
50. Critchfield, G.C., Willard, K.E.: Probabilistic analysis of decision trees using Monte Carlo simulation. Med. Decis. Making 6:85, 1986
51. Willard, K.E., Critchfield, G.C.: Probabilistic analysis of decision trees using symbolic algebra. Med. Decis. Making 6:93, 1986
52. Doubilet, P., Begg, C.B., Weinstein, M.C., Braun, P., McNeil, B.J.: Probabilistic sensitivity analysis using Monte Carlo simulation. Med. Decis. Making 5:157, 1985
53. Willan, A.R., O'Brien, B.J.: Cost effectiveness ratios in clinical trials: from deterministic to stochastic models. Health Econ. 5:297, 1996
54. Chaudhary, M.A., Stearns, S.C.: Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat. Med. 15:1447, 1996
55. Gardiner, J., Hogan, A., Holmes-Rovner, M., Rovner, D., Griffith, L., Kupersmith, J.: Confidence intervals for cost-effectiveness ratios. Med. Decis. Making 15:254, 1995
56. Wakker, P., Klaasen, M.P.: Confidence intervals for cost/effectiveness ratios. Health Econ. 4:373, 1995
57. Bloomfield, D.J., Krahn, M.D., Neogi, T., Panzarella, T.T.I., Smith, T.J., Warde, P., Willan, A.R., Tannock, I.F.: Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone resistant prostate cancer, based on a Canadian randomised trial with palliative endpoints. J. Clin. Oncol. 16:2272, 1998
58. Brown, M.L., Fintor, L.: Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res. Treat. 25:113, 1993
59. De Koning, H.J., van Ineveld, B.M., van Ootmarssen, G.J.: Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int. J. Cancer 49:531, 1991
60. Nutting, P.A., Calonge, B.N., Iverson, D.C., Green, L.A.: The danger of applying uniform clinical policies across populations: the case of breast cancer in American Indians. Am. J. Public Health 84:1631, 1994
61. Fahs, M.C., Mandelblatt, J., Schechter, C., Muller, C.: Cost effectiveness of cervical cancer screening for the elderly. Ann. Intern. Med. 117:520, 1992
62. Van Ineveld, B.M., Oortmarssen, G.J., de Koning, H.J., Boer, R., van der Maas, P.J.: How cost-effective is breast cancer screening in different EC countries? Eur. J. Cancer 29A:1663, 1993
63. Sackett, D.L., Haynes, R.B., Guyatt, G.H., Tugwell, P.: Clinical Epidemiology: A Basic Science for Clinical Medicine (2nd ed.). Boston, Little, Brown, 1991
64. Guyatt, G.H., Sackett, D.L., Cook, D.J.: Users' guides to the medical literature. II. How to use an article about therapy of prevention B: what were the results and will they help me in caring for my patients? J.A.M.A. 271:59, 1994
65. Dixon, J., Welch, H.G.: Priority setting: lessons from Oregon. Lancet 337:891, 1991
66. Hadorn, D.C.: Setting health care priorities in Oregon: cost effectiveness meets the rule of rescue. J.A.M.A. 265:2218, 1991
67. Kaplan, R.: Value judgment in the Oregon Medicaid experiment. Med. Care 32:975, 1994
68. Drummond, M., Torrance, G., Mason, J.: Cost-effectiveness league tables: more harm than good? Soc. Sci. Med. 37:33, 1993
69. Finlayson, S.R.G., Birkmeyer, J.D.: Cost-effectiveness analysis in surgery. Surgery 123:151, 1998
70. Laupacis, A., Feeny, D., Detsky, A.S., Tugwell, P.: How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can. Med. Assoc. J. 146:473, 1992
71. Barlow, C.W., Imber, C.J., Sharples, L.D., Heriot, A.G., Wells, F.C., Large, S.R.: Cost implications of mitral valve replacement versus repair in mitral regurgitation. Circulation 96(Suppl. II):90, 1997
72. Brasel, K.J., Borgstrom, D.C., Weigelt, J.A.: Cost-utility analysis of contaminated appendectomy wounds. J. Am. Coll. Surg. 184:23, 1997
73. Rubin, M., Horiuchi, K., Joy, N., Haun, W., Read, R., Ratzer, E., Fenoglio, M.: Use of fine needle aspiration for solid breast lesions is accurate and cost-effective. Am. J. Surg. 174:694, 1997
74. Rosemurgy, A.S., Bloomston, M., Zervos, E.E., Goode, S.E., Dobrimir, P., Zweibel, B., Black, T.J.: Transjugular intrahepatic portosystemic shunt versus H-graft portacaval shunt in the management of bleeding varices: a cost benefit analysis. Surgery 122:794, 1997
75. Rouse, D.J., Owen, J., Goldenberg, R.L., Cliver, S.P.: The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound. J.A.M.A. 276:1480, 1996
76. Smith, W.J., Blackmore, C.C.: Economic analyses in obstetrics and gynecology: a methodologic evaluation of the literature. Obstet. Gynecol. 91:472, 1998
77. Udvarhelyi, I.S., Colditz, G.A., Rai, A., Epstein, A.M.: Cost effectiveness and cost benefit analysis in the medical literature. Ann. Intern. Med. 116:238, 1992
78. Drummond, M.F., Jefferson, T.O.: Guidelines for authors and peer reviewers of economic submissions to the BMJ. B.M.J. 313:275, 1996
79. Siegel, J.E., Weinstein, M.C., Russell, L.B., Gold, M.R.: Recommendations for reporting cost-effectiveness analyses. J.A.M.A. 276:1339, 1996
80. Deber, R., Goel, V.: Using explicit decision rules to manage issues of justice, risk, and ethics in decision analysis: when is it not rational to maximize expected utility. Med. Dec. Making 10:181, 1990
81. Krahn, M., Naglie, G.: Principles of economic evaluation in cancer screening programs. In Advances in Cancer Screening, A.B. Miller, editor. New York, Kluwer Academic, 1996
82. Asch, D.A., Hershey, J.C.: Why some health policies don't make sense at the bedside. Ann. Intern. Med. 122:846, 1995
83. Ben-Zion, U., Gafni, A.: Evaluation of public investment in health care: is the risk irrelevant? J. Health Econ. 2:161, 1983
84. Gafni, A., Torrance, G.W.: Risk attitude and time preference in health. Manag. Sci. 30:440, 1984
85. Arrow, K.J., Lind, R.C.: Uncertainty and the evaluation of public investment. Am. Econ. Rev. 60:364, 1970
86. Eddy, D.: Cost effectiveness analysis: a conversation with my father. J.A.M.A. 267:1669, 1992
87. Eddy, D.: Cost effectiveness analysis: is it up to the task? J.A.M.A. 267:3342, 1992
88. Eddy, D.: Cost effectiveness analysis: will it be accepted? J.A.M.A. 268:132, 1992
89. Eddy, D.: Applying cost effectiveness analysis: the inside story. J.A.M.A. 268:2575, 1992
90. Powe, N.R.: Economic and cost-effectiveness investigations of radiologic practices. Radiology 192:11, 1994
91. Drummond, M.F., Richardson, W.S., O'Brien, B., Levine, M., Heyland, D.: Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? J.A.M.A. 277:1552, 1997
92. O'Brien, B.J., Heyland, D., Richardson, W.S., Levine, M., Drummond, M.F.: Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? J.A.M.A. 277:1802, 1997
93. Drummond, M.F., Stoddart, G.L., Torrance, G.W.: Principles of Economic Appraisal in Health Care. Oxford, Oxford University Press, 1980